Search for a trial

The Prostate CARE Study: Capecitabine (Xeloda??) combined with Rhenium-188-HEDP in hormone refractory prostate cancer patients with bone metastases; a Capecitabine phase I dose escalation study and phase II efficacy study.

The primary aim of the phase I part of this study is to establish the safety profile and to determine the maximum tolerated dose of capecitabine combined with Re-188-HEDP.The primary aim of the phase II part of this study is to obtain insight in the…

SEMINAL VESICLE MOTION RELATIVE TO THE PROSTATE

To quantify the motion of the seminal vesicles.

Clinical Evaluation of the PCA3 Assay in Men Requiring a Repeat Biopsy

To determine the performance characteristics (specificity, sensitivity, and positive and negative predictive values) of the PCA3 Assay using prostate biopsy as the reference method in men who are scheduled for a repeat prostate biopsy after a…